Golden
Cortexyme

Cortexyme

Cortexyme is a company developing novel treatments for Alzheimer's disease and other neurodegenerative disorders.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write a page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Casey Lynch

Chief Executive Officer, Co-Founder



Chris Lowe

Chief Financial Officer



David Hennings

Head of CMC



Kristen Gafric

Vice President of Operations, Co-Founder



Leslie Holsinger

Executive Vice President of Preclinical Development



Robert Galemmo

Vice President of Drug Discovery



Samer Kaba

Chief Marketing Officer



Steve Dominy

Chief Scientific Officer, Co-Founder



Further reading

Title
Author
Link
Type
Date

Cortexyme Completes $76 Million Series B Financing and Provides Update on Clinical Development Progress

Business Wire

News article



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services